```html

Yellowing of the Whites of the Eyes (Scleral Icterus)

What is Yellowing of the Whites of the Eyes?

Yellowing of the whites of the eyes, medically known as scleral icterus or conjunctival jaundice, is a visible discoloration of the sclera (the tough, white outer layer of the eyeball). The yellow hue occurs when excess bilirubin, a yellow‑orange breakdown product of red blood cells, accumulates in the bloodstream and deposits in eye tissues. Because the sclera is thin and highly vascular, even modest increases in bilirubin (usually >2 mg/dL) can make the change noticeable.

While occasional mild yellowing may be harmless, it is often a clue that something is affecting the liver, gallbladder, pancreas, red blood cells, or the body’s ability to process waste products. Recognizing scleral icterus early can prompt timely evaluation of potentially serious underlying conditions.

Common Causes

A wide range of disorders can raise serum bilirubin levels enough to cause scleral icterus. The most frequent culprits include:

• Hepatitis (viral, alcoholic, or autoimmune) – Inflammation damages liver cells, reducing bilirubin clearance.
• Alcohol‑related liver disease (cirrhosis, fatty liver) – Chronic alcohol abuse impairs bilirubin processing.
• Gallstones or biliary obstruction – Blocked bile flow forces bilirubin back into the bloodstream.
• Pancreatic cancer (especially at the head of the pancreas) – Can compress the common bile duct.
• Hemolytic anemia – Accelerated breakdown of red blood cells produces excess bilirubin.
• Genetic disorders (e.g., Gilbert’s syndrome, Crigler‑Najjar syndrome) – Impair the enzymes needed for bilirubin metabolism.
• Medication‑induced liver injury – Acetaminophen overdose, certain antibiotics, statins, and chemotherapy agents.
• Viral infections other than hepatitis (e.g., Epstein‑Barr, cytomegalovirus) – Can cause transient liver inflammation.
• Sepsis or severe infections – Lead to cholestasis (reduced bile flow) and jaundice.
• Neonatal jaundice – Common in newborns due to immature liver enzymes, but persistent yellowing after the first few weeks warrants evaluation.

Associated Symptoms

Yellowing of the eyes rarely occurs in isolation. Look for other signs that may point to the underlying cause:

• Yellowing of the skin (jaundice)
• Dark urine or pale, clay‑colored stools
• Abdominal pain, especially in the upper right quadrant
• Fatigue, weakness, or unexplained weight loss
• Fever, chills, or recent illness
• Itching (pruritus) without rash
• Swelling of the abdomen (ascites) or legs
• Nausea, vomiting, or loss of appetite
• Bruising or easy bleeding (suggesting impaired clotting)
• Joint pain or swelling (in autoimmune liver disease)

When to See a Doctor

Because scleral icterus often signals a systemic problem, prompt medical attention is recommended when any of the following occur:

• The yellowing is new, persistent, or worsening.
• You also notice yellowing of the skin or mucous membranes.
• There is abdominal pain, especially after meals.
• You have dark urine, pale stools, or unexplained itching.
• Fatigue, fever, or rapid weight loss accompany the yellowing.
• History of liver disease, gallstones, alcohol misuse, or recent medication changes.
• In children or infants, yellowing that does not improve within 2‑3 weeks of birth.

Diagnosis

Evaluation begins with a detailed history and physical exam. The clinician will specifically examine the sclera, skin, abdomen, and look for signs of chronic liver disease.

Laboratory Tests

• Comprehensive metabolic panel (CMP) – Includes liver enzymes (ALT, AST, ALP, GGT) and bilirubin (total and direct).
• Complete blood count (CBC) – Detects anemia, infection, or platelet abnormalities.
• Hepatitis serologies – Tests for hepatitis A, B, C, and sometimes E.
• Coagulation profile (PT/INR) – Assesses liver synthetic function.
• Serum lipase/amylase – Evaluates pancreatic involvement.
• Autoimmune markers (ANA, SMA, LKM‑1) – When autoimmune hepatitis is suspected.

Imaging Studies

• Ultrasound – First‑line to look for gallstones, bile duct dilation, or liver texture changes.
• CT or MRI abdomen – Provides detailed view of tumors, pancreatic masses, or complex biliary disease.
• MRCP (magnetic resonance cholangiopancreatography) – Non‑invasive test of the bile ducts.
• Endoscopic retrograde cholangiopancreatography (ERCP) – Both diagnostic and therapeutic for bile‑duct blockages.

Special Tests

• Liver biopsy – Occasionally required to differentiate between cirrhosis, fibrosis, or infiltrative disease.
• Genetic testing – For suspected hereditary bilirubin metabolism disorders.

Treatment Options

Treatment focuses on the underlying cause; the yellowing itself usually resolves once bilirubin levels normalize.

Medical Interventions

• Antiviral therapy for chronic hepatitis B or C (e.g., tenofovir, entecavir, direct‑acting antivirals).
• Corticosteroids or immunosuppressants for autoimmune hepatitis.
• Ursodeoxycholic acid for certain cholestatic liver diseases.
• Cholecystectomy or endoscopic stone removal when gallstones block the bile duct.
• Surgical resection, chemotherapy, or radiation for pancreatic or biliary cancers.
• Blood transfusion or steroids for acute hemolytic anemia.
• Adjustment or discontinuation of hepatotoxic medications, with close monitoring.

Home & Supportive Care

• Stay well‑hydrated; water helps the kidneys excrete bilirubin.
• Adopt a low‑fat, high‑fiber diet to reduce liver workload (lean proteins, whole grains, fruits, vegetables).
• Avoid alcohol completely if you have any liver disease.
• Limit over‑the‑counter pain relievers like acetaminophen to ≤2 g per day (or as directed by a physician).
• Take prescribed vitamins (e.g., vitamin K) if clotting is impaired and under doctor supervision.
• Use soothing skin moisturizers; itching can be uncomfortable but avoid harsh soaps.

Prevention Tips

While some causes (genetic disorders) cannot be avoided, many risk factors are modifiable:

• Limit alcohol intake – No more than one drink per day for women, two for men, or abstain if liver disease is present.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C transmission.
• Maintain a healthy weight; obesity increases the risk of non‑alcoholic fatty liver disease (NAFLD).
• Eat a balanced diet rich in antioxidants (berries, leafy greens) to support liver health.
• Use medications responsibly; follow dosing instructions and discuss liver‑affecting drugs with your clinician.
• Regular screening for liver function if you have risk factors (e.g., diabetes, high cholesterol, family history).
• Promptly treat infections and avoid prolonged use of antibiotics or other hepatotoxic drugs without supervision.

Emergency Warning Signs

---

References: Mayo Clinic. “Jaundice.”; CDC. “Hepatitis B.”; NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease.”; World Health Organization. “Viral Hepatitis.”; Cleveland Clinic. “Biliary Colic & Gallstones.”; Peer‑reviewed articles in The Lancet Gastroenterology & Hepatology (2022) and Journal of Hepatology (2021).

```